Welcome to the new morningstar.co.uk! Learn more about the changes and how our new features help your investing success.

Velocys Amends Licencing Contract With Red Rock Biofuels

LONDON (Alliance News) - Velocys PLC said Tuesday it has amended its licencing contracts with Red ...

Alliance News 12 February, 2019 | 2:20PM
Email Form

LONDON (Alliance News) - Velocys PLC said Tuesday it has amended its licencing contracts with Red Rock Biofuels LLC.

The amendments were made at the request of Red Rock Biofuels and allows it to complete the Lakeview bio-refinery project on a new timeline. The refinery is located in the US state of Oregon.

Velocys will accelerate delivery of the first of four reactors and the first catalyst. Velocys will also reduce its firm commitment for reactors to four from six but Red Rock will retain an option to acquire reactors five and six until the end of 2020.

Velocys expects the amendments to add to its near-term cash flow of about USD1.1 million but a decrease in revenue of about USD3 million. The total value of the contract is USD15 million.

"We collaborated with RRB to re-optimise the original agreement to help them complete the biorefinery on their desired timeline. This is an opportunity for us to demonstrate our commitment to delivering for our client the central processing unit in their biorefinery that will convert woody biomass to renewable jet fuel and diesel in Oregon," said Chief Executive Henrik Wareborn.

Shares in Velocys were up 0.6% Tuesday at 3.95 pence each.

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

Email Form

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Velocys PLC 1.95 GBX -0.69 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

Audience Confirmation

By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites